Evidence map›Paper›PMID 37046590›Full record

ArticleCancers2023

Management of Barrett's Esophagus: Practice-Oriented Answers to Clinical Questions.

Rocco Maurizio Zagari, Veronica Iascone, Lorenzo Fuccio, Alba Panarese, Leonardo Frazzoni

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rocco Maurizio ZagariDepartment of Digestive Diseases, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0001-9949-8619
Veronica IasconeDepartment of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Lorenzo FuccioDepartment of Digestive Diseases, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
Alba PanareseDivision of Gastroenterology and Digestive Endoscopy, Department of Medical Sciences, Central Hospital, Azienda Ospedaliera, 74100 Taranto, Italy.
Leonardo FrazzoniDepartment of Digestive Diseases, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0001-7084-6157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Barrett's esophagus is the most important complication of gastro-esophageal reflux disease and the only known precursor of esophageal adenocarcinoma. The diagnosis and treatment of Barrett's esophagus are clinically challenging as it requires a high level of knowledge and competence in upper gastrointestinal endoscopy. For instance, endoscopists should know when and how to perform biopsies when Barrett's esophagus is suspected. Furthermore, the correct identification and treatment of dysplastic Barrett's esophagus is crucial to prevent progression to cancer as well as it is the endoscopic surveillance of treated patients. Herein, we report practice-oriented answers to clinical questions that clinicians should be aware of when approaching patients with Barrett's esophagus.

Indexed as

Barrettdiagnosisesophagustherapy

Identifiers

PMID37046590
PMCPMC10093467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.